Veterinary Medicines

DOLPAC MEDIUM DOGS TABLETS

Authorised
  • Oxantel pamoate
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
DOLPAC MEDIUM DOGS TABLETS
DOLPAC Tabletten für mittelgroße Hunde
Active substance:
  • Oxantel pamoate
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Oxantel pamoate
    559.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Vetoquinol GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401052.01.00
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0183/002
Concerned member states:
  • Austria
  • Cyprus
  • Czechia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/01/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."